Dr. Reddy's IBU 600mg Tablets Recall: Failed Tablet Specifications
Dr. Reddy's recalls 600mg ibuprofen tablets (500-count, Rx only) due to failed tablet specifications. Affected lots made in India, expiring March 2028. Consumers should contact for details.
Recall notice
Failed Tablet/Capsule Specifications
Contact the company
What happened, in plain English
Dr. Reddy's is recalling 600mg ibuprofen tablets (500-count, prescription-only) because they failed tablet specifications. This means the tablets may not meet quality standards, though the exact risk isn't specified in the recall. Read more at govinfonow.com/recall/32482-dr-reddy-s-ibu-600mg-tablets-recall-failed-tablet-specifications.
Source Summary by GovInfoNow · govinfonow.com/recall/32482-dr-reddy-s-ibu-600mg-tablets-recall-failed-tablet-specifications · Updated September 23, 2026 · FDA enforcement record: FDA #D-0047-2025
Cite this page
“Dr. Reddy's IBU 600mg Tablets Recall: Failed Tablet Specifications.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32482-dr-reddy-s-ibu-600mg-tablets-recall-failed-tablet-specifications. Based on FDA recall #D-0047-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0047-2025%22&limit=1).
Why it’s dangerous
The tablets failed to meet specified quality standards, which could mean they don't contain the correct amount of ibuprofen or have other issues that might affect safety. However, the recall does not specify the exact hazard or how serious it is.
Who’s affected
Prescription holders of Dr. Reddy's 600mg ibuprofen tablets (500-count bottles) made in India with lot number C5406201, expiring March 2028. People using these tablets for pain or inflammation are most at risk.
How to tell if you have this one
Check for the 500-count bottle of 600mg ibuprofen tablets labeled as Rx only. Look for the lot number C5406201 and expiration date of 03/31/2028. The product was made in India.
- Brand
Dr. Reddy's- Category
Drug
What to do — step by step
Check Product Details
Identify the lot number (C5406201) and expiration date (03/31/2028) on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 29 days after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Dr. Reddy's recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0047-2025 (October 29, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0047-2025 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.